ru 24926 has been researched along with racemetirosine in 2 studies
| Studies (ru 24926) | Trials (ru 24926) | Recent Studies (post-2010) (ru 24926) | Studies (racemetirosine) | Trials (racemetirosine) | Recent Studies (post-2010) (racemetirosine) |
|---|---|---|---|---|---|
| 30 | 0 | 0 | 1,165 | 45 | 96 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Protais, P; Vasse, M | 1 |
| Bergstrom, DA; Braun, AR; Carlson, JH; Chase, TN; Walters, JR | 1 |
2 other study(ies) available for ru 24926 and racemetirosine
| Article | Year |
|---|---|
Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; alpha-Methyltyrosine; Amisulpride; Animals; Apomorphine; Corpus Striatum; Cyclic AMP; Dopamine Antagonists; Drug Synergism; In Vitro Techniques; Male; Methyltyrosines; Metoclopramide; Mice; Phenethylamines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Stereotyped Behavior; Sulpiride | 1989 |
D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Basal Ganglia; Benzazepines; Dopamine; Ergolines; Methyltyrosines; Neurons; Phenethylamines; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior | 1987 |